title: [Does spironolactone use at arterial hypertension therapy protect endothelium also in smoking patients?].
authors.affiliation: Katedra Chemii i Biochemii Klinicznej, Zakład Biochemii Klinicznej Uniwersytet Medyczny im. Karola Marcinkowskiego Poznań.
authors.forename: Hanna
authors.initials: H
authors.lastname: Kara-Perz
authors.forename: Teresa
authors.initials: T
authors.lastname: Kosicka
authors.forename: Stanisław
authors.initials: S
authors.lastname: Perz
mesh_terms: D000450:Aldosterone / Q000097:blood; D004232:Diuretics / Q000627:therapeutic use; D019332:Endothelin-1 / Q000378:metabolism*; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000378:metabolism; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D012083:Renin / Q000097:blood; D012907:Smoking / Q000378:metabolism*; D013148:Spironolactone / Q000627:therapeutic use*
chemical_list: D004232:Diuretics; D019332:Endothelin-1; D013148:Spironolactone; D000450:Aldosterone; D012083:Renin
vernacular_title: Czy spironolakton stosowany w terapii nadciśnienia tetniczego chroni sródbłonek naczyniowy takze u osób palacych tytoń?